Objective: The aim of this study was to evaluate the long-term fate of the cryopreserved mitral homograft focusing on structural valve deterioration.
Methods: Homograft replacement of the mitral valve was performed in 106 patients. The causes of mitral disease were rheumatic disease (n=75), endocarditis (n=24), and others (n=7). There were 40 partial homografts and 66 total homografts.
Results: Mean follow-up was 9.3+4.7 years (up to 17.8 years). There were 5 early (<3 months) and 15 late deaths. There have been 5 early (<3 months) and 30 late reoperations. Five patients had endocarditis, and 5 patients had an ischemic/hemorrhagic event. Compared with baseline, follow-up echography showed progression of mitral regurgitation grade (from 0.4 to 1.3; P<.001) with stenosis (elevated gradient: from 3.9 to 7.0 mm Hg; P<.001) and decreased valve area (from 2.3 to 1.7 cm2, P<.001). Freedom from structural valve deterioration was 90%, 76%, and 65% at 5, 10, and 15 years, respectively. Structural valve deterioration was more frequent in total homografts (P=.018 vs partial homografts) and in case of pregnancy (P=.016 vs no pregnancy). Stenosis related to structural valve deterioration was more pronounced for age less than 40 years (P=.03) and ring size 30 mm or less (P=.002). Pathologic analysis of the explanted homografts almost invariably showed dense fibrosis with calcification and no cellularity.
Conclusions: Mitral homografting was accomplished with early echographic results similar to those of valve repair. Structural valve deterioration produced mixed stenosis with insufficiency, and its incidence was comparable to that of bioprostheses structural valve deterioration. An improvement in the preservation mode of valvular homografts is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtcvs.2011.06.041 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Homograft implant for prosthetic aortic endocarditis with paravalvular abscess in a patient with persistent left superior vena cava.
Multimed Man Cardiothorac Surg
October 2024
Department of Cardiothoracic Surgery, Cardiovascular Research Institute-Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Article Synopsis
- A patient with prosthetic aortic valve endocarditis faced severe complications, necessitating urgent surgery due to significant valve detachment and prior cardiac surgeries.
- Preoperative imaging uncovered a rare left superior vena cava anomaly, which required special techniques for safe surgery.
- The surgical procedure involved removing the infected valve and tissue, then replacing it with a cryopreserved aortic homograft for better fit and function.
Infected stent graft and severe aortitis after transcaval glue embolization of type II endoleak: a case report.
AME Case Rep
May 2024
Department of Radiology, Mayo Clinic Health System, Eau Claire, WI, USA.
Article Synopsis
- - Type II endoleaks are common after aortic stent graft procedures, often requiring treatment such as transarterial or trans-caval embolization, but complications like infections can arise, as highlighted in a unique case study.
- - A 71-year-old male developed an infected Gore Excluder stent graft following trans-caval embolization for a type II endoleak, which was complicated by rapid sac enlargement and difficult-to-diagnose inflammation.
- - After two weeks of pre-surgery optimization due to the patient's high surgical risk, the infected graft was surgically removed, revealing adhesion to nearby intestines, and the patient recovered with only minor postoperative issues.
Original technique for tricuspid valve replacement by mitral homograft: Step-by-step approach and initial results.
J Card Surg
December 2022
Department of Radiology, State Budgetary Healthcare Institution "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Russian Federation.
Introduction: Severe tricuspid regurgitation is associated with the progression of heart failure symptoms and poor survival. Surgical treatment of infective and prosthetic tricuspid valve endocarditis using homografts gives promising early and midterm results. Tricuspid valve replacement with a mitral homograft is a reasonable procedure with a challenging technique.
View Article and Find Full Text PDFCryopreserved aortic homografts for complex aortic valve or root endocarditis: a 28-year experience.
Eur J Cardiothorac Surg
August 2022
Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, AOUI of Verona, University of Verona, Italy.
Objectives: The aim of this study was to evaluate early- and long-term outcomes of cryopreserved aortic homograft (CAH) implantation for aortic valve replacement (AVR) or aortic root replacement (ARR) in patients with or without complex infective endocarditis.
Methods: All adult patients undergoing AVR or ARR with CAH at our institution between January 1993 and July 2021 were included in the study.
Results: One hundred four patients, 75 males and 29 females, aged 59 ± 17 years, underwent AVR or ARR with CAH for infective endocarditis (n = 94, 90%) or aortic valve disease (n = 10, 10%).
We report about a 61-year-old man who, 6 years after initial uncomplicated mitral valve repair and 3 months after treatment of a pseudo-aneurysm of the ascending aorta with a Dacron patch, was admitted in our institution with an infection of the vascular graft, which was associated with sternal osteomyelitis and purulent cutaneous fistula. In a re-redo procedure, the proximal aortic arch and the ascending aorta were replaced with a cryopreserved aortic homograft. The infected part of the sternum was resected and the defect was covered by mobilizing the mediastinal tissue and with a bilateral muscle flap.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!